» Articles » PMID: 25185110

Vitamin C Revisited

Overview
Journal Crit Care
Specialty Critical Care
Date 2014 Sep 4
PMID 25185110
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

This narrative review summarizes the role of vitamin C in mitigating oxidative injury-induced microcirculatory impairment and associated organ failure in ischemia/reperfusion or sepsis. Preclinical studies show that high-dose vitamin C can prevent or restore microcirculatory flow impairment by inhibiting activation of nicotinamide adenine dinucleotide phosphate-oxidase and inducible nitric oxide synthase, augmenting tetrahydrobiopterin, preventing uncoupling of oxidative phosphorylation, and decreasing the formation of superoxide and peroxynitrite, and by directly scavenging superoxide. Vitamin C can additionally restore vascular responsiveness to vasoconstrictors, preserve endothelial barrier by maintaining cyclic guanylate phosphatase and occludin phosphorylation and preventing apoptosis. Finally, high-dose vitamin C can augment antibacterial defense. These protective effects against overwhelming oxidative stress due to ischemia/reperfusion, sepsis or burn seems to mitigate organ injury and dysfunction, and promote recovery after cardiac revascularization and in critically ill patients, in the latter partially in combination with other antioxidants. Of note, several questions remain to be solved, including optimal dose, timing and combination of vitamin C with other antioxidants. The combination obviously offers a synergistic effect and seems reasonable during sustained critical illness. High-dose vitamin C, however, provides a cheap, strong and multifaceted antioxidant, especially robust for resuscitation of the circulation. Vitamin C given as early as possible after the injurious event, or before if feasible, seems most effective. The latter could be considered at the start of cardiac surgery, organ transplant or major gastrointestinal surgery. Preoperative supplementation should consider the inhibiting effect of vitamin C on ischemic preconditioning. In critically ill patients, future research should focus on the use of short-term high-dose intravenous vitamin C as a resuscitation drug, to intervene as early as possible in the oxidant cascade in order to optimize macrocirculation and microcirculation and limit cellular injury.

Citing Articles

Characterization and comparison of gut microbiota in patients with acute pancreatitis by metagenomics and culturomics.

Gong L, Li X, Ji L, Chen G, Han Z, Su L Heliyon. 2025; 11(3):e42243.

PMID: 39931490 PMC: 11808722. DOI: 10.1016/j.heliyon.2025.e42243.


Metabolic response to burn injury: a comprehensive bibliometric study.

Li Y, Liu Y, Xie S, Zhu Y, Ding X, Zhang W Front Med (Lausanne). 2025; 11():1451371.

PMID: 39830385 PMC: 11739346. DOI: 10.3389/fmed.2024.1451371.


Early intravenous high-dose vitamin C in postcardiac arrest shock (VICEPAC): study protocol for a randomised, single-blind, open-label, multicentre, controlled trial.

Chelly J, Peres N, Sboui G, Maizel J, Beuzelin M, Nigeon O BMJ Open. 2024; 14(9):e087303.

PMID: 39317492 PMC: 11429356. DOI: 10.1136/bmjopen-2024-087303.


The Effect of Ascorbic Acid on Hepatic Ischaemia-Reperfusion Injury in Wistar Rats: An Experimental Study.

Ximenes J, Rocha-Filho J, Galvao F, Lanchotte C, Kubrusly M, Leitao R Int J Mol Sci. 2024; 25(16).

PMID: 39201519 PMC: 11354593. DOI: 10.3390/ijms25168833.


Association between serum vitamin C and body mass index in adolescents aged 12-19 years.

Su X, Patel N, Chen J, Chen Y, Zhou X, Mo X BMC Public Health. 2024; 24(1):2067.

PMID: 39085802 PMC: 11293171. DOI: 10.1186/s12889-024-19588-2.


References
1.
Auer B, Auer D, Rodgers A . Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest. 1998; 28(9):695-700. DOI: 10.1046/j.1365-2362.1998.00349.x. View

2.
Padayatty S, Sun H, Wang Y, Riordan H, Hewitt S, Katz A . Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004; 140(7):533-7. DOI: 10.7326/0003-4819-140-7-200404060-00010. View

3.
Schorah C, Downing C, Piripitsi A, Gallivan L, Sanderson M, Bodenham A . Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996; 63(5):760-5. DOI: 10.1093/ajcn/63.5.760. View

4.
Rumelin A, Humbert T, Luhker O, Drescher A, Fauth U . Metabolic clearance of the antioxidant ascorbic acid in surgical patients. J Surg Res. 2005; 129(1):46-51. DOI: 10.1016/j.jss.2005.03.017. View

5.
Borrelli E, Roux-Lombard P, Grau G, Girardin E, Ricou B, Dayer J . Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996; 24(3):392-7. DOI: 10.1097/00003246-199603000-00006. View